These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Sex differences in presentation and outcome among patients with type 2 diabetes and coronary artery disease treated with contemporary medical therapy with or without prompt revascularization: a report from the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation 2 Diabetes). Tamis-Holland JE; Lu J; Korytkowski M; Magee M; Rogers WJ; Lopes N; Mighton L; Jacobs AK; J Am Coll Cardiol; 2013 Apr; 61(17):1767-76. PubMed ID: 23500245 [TBL] [Abstract][Full Text] [Related]
8. Interpreting the results of the COURAGE trial: a non-interventionalist perspective. Boden WE Rev Cardiovasc Med; 2009; 10 Suppl 2():S34-44. PubMed ID: 19898280 [TBL] [Abstract][Full Text] [Related]
9. Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial. Rezende PC; Hueb W; Garzillo CL; Lima EG; Hueb AC; Ramires JA; Kalil Filho R J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1105-12. PubMed ID: 22944095 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic strategies in patients with chronic stable coronary artery disease. Zellweger MJ; Pfisterer ME Cardiovasc Ther; 2011 Dec; 29(6):e23-30. PubMed ID: 20491783 [TBL] [Abstract][Full Text] [Related]
11. One year perspective on COURAGE. Tommaso CL Catheter Cardiovasc Interv; 2008 Sep; 72(3):426-429. PubMed ID: 18727125 [TBL] [Abstract][Full Text] [Related]
12. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons. Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ; Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114 [TBL] [Abstract][Full Text] [Related]
17. Ischemia is the critical determinant of revascularization benefit: an interventionalist's perspective of the COURAGE trial. Kereiakes DJ Rev Cardiovasc Med; 2009; 10 Suppl 2():S45-52. PubMed ID: 19898281 [TBL] [Abstract][Full Text] [Related]
18. Percutaneous coronary intervention versus medical therapy in stable coronary artery disease: the unresolved conundrum. Epstein SE; Waksman R; Pichard AD; Kent KM; Panza JA JACC Cardiovasc Interv; 2013 Oct; 6(10):993-8. PubMed ID: 24156960 [TBL] [Abstract][Full Text] [Related]
19. Quality of life and health status after percutaneous coronary intervention in stable angina patients: results from the real-world practice. de Quadros AS; Lima TC; Rodrigues AP; Modkovski TB; Welter DI; Sarmento-Leite R; Gottschall CA Catheter Cardiovasc Interv; 2011 Jun; 77(7):954-60. PubMed ID: 20824752 [TBL] [Abstract][Full Text] [Related]
20. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina. Latib A; Chieffo A; Colombo A Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):92-3. PubMed ID: 19065124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]